Score for nutritional status evaluation: The role played in the prognostic stratification of dilated cardiomyopathy and advanced heart failure patients;Escore para avaliação do estado nutricional. Seu valor na estratificação prognóstica de portadores de cardiomiopatia dilatada e insuficiência cardíaca avançada

Arquivos Brasileiros de Cardiologia

Volumn 87, Issue 2, 2006, Pages 178-184

  Veloso, Luiz Guilherme ^a   Pereira Barretto, Antonio Carlos ^a,b   De Oliveira Jr , Mucio Tavares ^a   Munhoz, Robson Tadeu ^a   Morgado, Paulo César ^a   Ramires, José Antonio Franchini ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Cardiac cachexia; Dilated cardiomyopathy; Malnutrition

Indexed keywords

SERUM ALBUMIN;

ADULT; ARM MUSCLE; ARTICLE; BODY WEIGHT; CONGESTIVE CARDIOMYOPATHY; FEMALE; HEART FAILURE; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MUSCLE MASS; NUTRITIONAL STATUS; PROGNOSIS; SCORING SYSTEM; SKINFOLD THICKNESS;

EID: 33748431649     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/s0066-782x2006001500017     Document Type: Article

References (37)

1. Katz AM, Katz PB. Diseases of the heart in works of Hyppocrates. Br Heart J. 1962; 24: 256-64.
2. Pittman JG, Cohen P. The pathogenesis of cardiac cachexia. N Engl J Med. 1964; 271: 403-9.
3. Gottdiener JS, Gross HA, Henry WL, Borer JS, Ebert, MH. Effects of self-induced starvation on cardiac size and function in anorexia nervosa. Circulation. 1978; 58 (3): 425-33.
4. Alden PB, Madoff RD, Stahl TJ, Lakatua DJ, Ring WS, Cerra FB. Left ventricular function in malnutrition. Am J Physiol. 1987; 253 (suppl H): H380-H387.
5. Ansari A. Syndromes of cardiac cachexia and the cachetic heart: current perspective. Prog Cardiovasc Dis. 1987; 30: 45-60.
6. Morrison WL, Edwards RHT. Cardiac cachexia - We know about the mechanisms but not how to reverse it. Brit Med J. 1991; 302: 301-2.
7. Anker SD, Sharma R. The syndrome of cardiac cachexia. Int J Cardiol. 2002; 85: 57-66.
8. Conraads VM, Bosmans JM, Vrints CJ. Chronic heart failure: an example of a systemic inflammatory disease resulting in cachexia. Int J Cardiol. 2002; 85: 33-49.
9. Velloso LGC, Csengeri LF, Alonso RR, Ciscato CML, Pereira-Barretto AC, Bellotti G, et al. Desnutrição na miocardiopatia dilatada: correlação com índices ecocardiográficos da função ventricular esquerda. Arq Bras Cardiol. 1992; 58: 189-92.
10. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumor necrosis factor in "cachetic" patients with severe chronic heart failure. Br Heart J. 1991; 66: 356-8.
11. Bollet AJ, Owens S. Evaluation of nutritional status of selected hospitalized patients. Am J Clin Nutr. 1973; 26: 931-8.
12. Carr JG, Stevenson LW, Walden JA, Heber D. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1989; 63: 709-13.
13. Bernard MA, Jacobs DO, Rombeau JL. Suporte nutricional e metabólico de pacientes hospitalizados. Rio de Janeiro: Guanabara, 1988. Cap.3, 24-42: Avaliação Nutricional.
14. Jelliffe DB, Jelliffe EFP. Community nutritional assessment - With special reference to less technically developed countries. New York: Oxford University Press, 1989, 56-550.
15. Blackburn GL, Bistrian BR, Mains BS. Nutritional and metabolic assessment of the hospitalized patients. J Parent Ent Nutr. 1977; 1: 11-22.
16. Jelliffe DB. The assessment of the nutritional status of the community - With special reference to field surveys in developing regions of the world. Geneve. WHO Monograph Series, 1966; 53: 50-242.
17. Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr. 1981; 34: 2540-5.
18. Torosian MH, Mullen JL. Nutritional assessment. In: Kaminski MV ed. Hyperalimentation: a guide for clinicians. New York: Marcel Dekker Inc; 1985. p. 47-75.
19. Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997; 349: 1050-53.
20. Anker SD, Rauchhaus M. Insights into the pathogenesis of chronic heart failure: immune activation and cachexia. Curr Opin Cardiol. 1999; 14: 211-16.
21. Buzby GP, Mullen JL, Matthews DC, Hobbs CL, Rosato EF. Prognostic nutritional index in gastrointestinal surgery. Am J Surg. 1980; 139: 160-7.
22. Horwich TB, Fonarow GC, Hamilton MA, et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001; 38: 789-95.
23. Anker SD, Coats AJS. Cardiac cachexia. A syndrome with impaired survival and immune and neuroendocrine activation. Chest. 1999; 115: 836-47.
24. Veloso LGC, Pereira-Barretto AC, Oliveira Jr MT, Munhoz RT, Morgado PC, Ramires JAF. Repercussão nutricional na cardiomiopatia dilatada e seu valor na avaliação prognóstica de portador de insuficiência cardíaca em forma avançada. Arq Bras Cardiol. 2005; 84: 480-85.
25. Cohn JN, Levine B, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984; 311(13): 819-23.
26. Packer M, Lee WH, Kessler PD, Gottlieb SS, Bernstein JL, Kukin ML. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. Circulation. 1987; 75 (suppl. IV): 80-92.
27. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation. 1986; 73: 257-67.
28. Parameshwar J, Keegan J, Sparrow J, Sutton GC, Poole-Wilson PA. Predictors of prognosis in severe chronic heart failure. Am Heart J. 1992; 123: 421-6.
29. Saxon LA, Stevenson WG, Middlekauff HR, Fonarow G, Woo M, Moser D, et al. Predicting Death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1993; 72: 62-5.
30. Franciosa JA. Why patients with heart failure die: hemodynamic and functional determinants of survival. Circulation. 1987; 75 (suppl IV): 20-7.
31. Schwartz F, Mall G, Zebe H, Schmitzer E, Manthey J, Scheurlen H, et al. Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics. Circulation. 1984; 70(6): 923-8.
32. Unverferth DV, Magorien RD, Moeschberger ML, Baker PB, Fetters JK, Leier CV. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol. 1984; 54: 147-52.
33. Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, et al, for the Captopril-Digoxin Study Group. Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol. 1989; 14: 546-70.
34. Cohn JN, Johnson GR, Shabetai R, Loeb H, Tristani F, Rector T, et al, for the V-HeFT VA Cooperative Studies Group. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhytmias and plasma norepinephrine as determinants of prognosis in heart failure. Circulation. 1993; 87 (suppl VI): 5-16.
35. Mady C, Cardoso RHA, Pereira-Barretto AC, Luz PL, Bellotti G, Pileggi F. Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation. 1994; 90: 3098-102.
36. Canesin MF, Giorgi D, Oliveira Jr MT, Wajngarten M, Mansur A, Ramires JAF, et al. Ambulatory blood pressure monitoring of patients with heart failure. A new prognosis marker. Arq Bras Cardiol. 2002; 78: 83-89.
37. Del Carlo CH, Pereira-Barretto AC, Cassaro-Strunz C, Latorre MRDO, Ramires JAF. Serial measure of cardiac troponin T levels for prediction of clinical events in decompensated heart failure. J Cardiac Fail. 2004; 10: 43-48.